John Renger, Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 10,000 shares at $35.00 ($350K) on 2021-12-23, disclosed to the SEC on 2021-12-28.
Open-market sale of $350k CERE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 5,873 | $206K | 58.7% |
| 2 | $35.00 | 4,127 | $144K | 41.3% |
| Total | $35.00 avg | 10,000 | $350K | 100% |
| Filing → |
| CERE | SELL | 2022-10-06 | $750K | — | Filing → |
| CERE | SELL | 2022-08-12 | $4.5M | — | Filing → |
| CERE | SELL | 2022-08-09 | $1.0M | — | Filing → |